Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current data on rheumatoid factors]

P Youinou1, P Le Goff

  • 1Laboratoire d'Immunologie, CHU, Brest.

Revue Du Rhumatisme (Ed. Francaise : 1993)
|December 15, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tritium levels in milk in the vicinity of chronic tritium releases.

Journal of environmental radioactivity·2015
Same author

Roles of heat shock factor 1 and 2 in response to proteasome inhibition: consequence on p53 stability.

Oncogene·2010
Same author

Prevalences of rheumatoid arthritis in Roman Catholic nuns and the general female population in Brittany, France: a pilot study.

Clinical and experimental rheumatology·2005
Same author

Poor predictive value of antinucleosome and antineutrophil cytoplasmic antibodies in a 270 inception cohort of patients with early naked arthritis of less than one year's duration.

Annals of the rheumatic diseases·2002
Same author

Confidence in the diagnosis of early spondylarthropathy: a prospective follow-up of 270 early arthritis patients.

Clinical and experimental rheumatology·2002
Same author

Differences in understanding and application of 1987 ACR criteria for rheumatoid arthritis and 1991 ESSG criteria for spondylarthropathy. A pilot survey.

Clinical and experimental rheumatology·2002
Same journal

Revue du rhumatisme (Ed. francaise : 1993)·2022
Same journal

Revue du rhumatisme (Ed. francaise : 1993)·2022
Same journal

Revue du rhumatisme (Ed. francaise : 1993)·2022
Same journal

Revue du rhumatisme (Ed. francaise : 1993)·2022
Same journal

Revue du rhumatisme (Ed. francaise : 1993)·2022
Same journal

Mécanisme d'action du méthotrexate dans le traitement de la polyarthrite rhumatoïde.

Revue du rhumatisme (Ed. francaise : 1993)·2022
See all related articles

Rheumatoid factors are autoantibodies targeting IgG fragments. Polyclonal rheumatoid factors in autoimmune diseases differ from monoclonal ones in lymphoproliferative disorders, suggesting distinct origins and roles in immune responses.

Area of Science:

  • Immunology
  • Autoimmunity

Context:

  • Rheumatoid factors (RFs) are autoantibodies targeting the Fc fragment of immunoglobulins G (IgGs).
  • Distinguishing between polyclonal RFs in autoimmune diseases and monoclonal RFs in lymphoproliferative disorders is crucial.
  • Understanding the origin and function of RFs is key to deciphering immune complex-mediated pathologies.

Purpose:

  • To differentiate polyclonal rheumatoid factors from monoclonal rheumatoid factors based on their characteristics.
  • To explore the potential derivation of rheumatoid factors from natural autoantibodies.
  • To elucidate the potential role of natural rheumatoid factors in antigen presentation to T cells.

Summary:

  • Polyclonal rheumatoid factors, prevalent in autoimmune diseases, rarely express public idiotypes, show Fc specificity, and have higher affinity compared to monoclonal rheumatoid factors found in lymphoproliferative disorders.

Related Experiment Videos

  • These polyclonal rheumatoid factors may originate from natural rheumatoid factors.
  • Natural rheumatoid factors might play a role in presenting immune complex antigens to T cells, influencing autoimmune responses.

    • Impact:

    • Provides a clearer distinction between different types of rheumatoid factors.
    • Suggests a potential pathway for the development of autoimmune responses involving natural autoantibodies.
    • Highlights a possible mechanism for T cell activation in the context of immune complex diseases.